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RNA silencing is a newly
discovered mechanism of genetic
regulation in eukaryotes. It is
based on an immune system that
protects eukaryotes against
viruses and transposons and in
some respects it is conceptually
similar to classical humoral
immunity. However RNA silencing
is distinct from humoral immunity
in that it only targets nucleic 
acids and has a specificity
mechanism based on nucleic acid
base pairing rather than on
interactions with protein
antibodies.
Five years ago the evidence for
RNA silencing was based on
mysterious experimental
observations in plants, a fungus
and in Caenorhabditis elegans.
Today we know that this process
has natural biological roles and we
have an outline understanding of
the mechanisms. In addition RNA
silencing is part of powerful
enabling technologies for
functional genomics. The story of
this recent progress is revealing
about the way that science
accommodates and adapts to
unexpected results. It also
illustrates the power of combined
molecular, genetic and biochemical
approaches to problems in biology.
Several terms are used to




suppression’ and ‘quelling’. Here I
use ‘RNA silencing’ generically;
the other terms are useful in more
specific examples of RNA
silencing. For example,
‘cosuppression’ refers to the
specific case of RNA silencing in
which RNAs of a transgene and
homologous endogenous gene
are co-ordinately suppressed;
‘quelling’ is cosuppression in
Neurospora crassa; ‘RNA
interference’ occurs when direct
introduction of a double stranded
RNA causes specific silencing of a
homologous endogenous gene.
Basic Mechanism of RNA Silencing
The first evidence for RNA
silencing was from plants and fungi
carrying transgenic copies of
endogenous genes. These plants
and fungi were expected to
overexpress the corresponding
protein, however the result, at least
in some of the lines, was the exact
opposite. For example, in plants
that should have overexpressed
an enzyme required for floral
pigment production, the enzyme
was absent and flowers were white
(Figure 1). We now know that the
white flowers were due to an RNA
silencing surveillance system that
detects the presence of foreign
RNA in eukaryotic cells. This
system recruits the foreign nucleic
acid as the specificity determinant
of an RNA targeting mechanism.
Thus, a transgene X causes
specific degradation of X RNA and
a floral pigmentation transgene
causes the degradation of the
transgene and endogenous RNAs
encoding the floral pigmention
enzyme. Other endogenous RNAs
Figure 1. RNA silencing in petunia.
The petunia plant was transformed with
an additional copy of a gene (chalcone
synthase) required for pigment
production. The transgene activated
RNA silencing so that expression of
both the transgene and the endogenous
gene was suppressed. The flowers
would normally have been purple.
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are unaffected because they did
not share nucleotide sequence
similarity with the transgene RNA.
To explain the sequence
specificity of RNA silencing it
seemed likely that antisense RNA
would be involved. This antisense
RNA would anneal by base pairing
with the target RNA and thereby
prevent translation or provide a
target for nuclease degradation.
However, in plants, the
transgenes  with an RNA silencing
phenotype were designed to
produce sense rather than
antisense RNA. Similarly, in C.
elegans, injection of sense RNA
caused sequence-specific
silencing of endogenous RNAs.
These unexpected results with
sense RNA were eventually
explained in terms of double-
stranded (ds)RNA. The sense
transgenes were mosaics of
multiple inserts with inverted
repeats that would be transcribed
into dsRNA. Similarly the sense
RNAs injected into C. elegans
contained a small amount of
contaminating double-stranded
(ds)RNA. Deliberate injection or
transgenic expression of dsRNA
produces very efficient silencing.
dsRNA is important in RNA
silencing because it is processed
into short (21–25 nucleotide) RNAs
by an enzyme known as DICER.
DICER is a homologue of E. coli
RNAseIII with dsRNA binding and
helicase domains. The short RNAs,
known as small interfering or
(si)RNAs, correspond to both
sense and antisense strands of the
target RNA and are incorporated
into a multimeric RNase complex
— RNA Interference Specificity
Complex- RISC — that is guided
to its target RNA by Watson-Crick
base pairing. Thus the
DICER/RISC process (Figure 2)
ensures that RNA species are
degraded if they share sequence
similarity with the dsRNA. One of
the components of RISC is a
protein, AGO2, that shares some
limited sequence similarity, in the
PAZ domain, with DICER. It has
been suggested that interactions
of the PAZ domains may allow
transfer of siRNAs from RISC to
DICER.
In mammals the investigation of
RNA silencing is complicated by
the dsRNA-dependent protein
kinase (PKR) system in which
dsRNA is an activator of cell death.
This system, as far as we know, is
quite distinct from RNA silencing.
However more recently it has
become apparent that RNA
silencing does operate in
mammals. They express a homo-
logue of DICER and have an RNA
silencing response if dsRNA is
introduced in the form of siRNAs,
or into embryonic cells in which
the PKR system is not active. 
Intercellular signaling and
amplification of RNA silencing
A remarkable feature of RNA
silencing is its ability to act
beyond the cells in which it is
initiated. For example, in plants
carrying an expressed GFP
transgene, RNA silencing can be
initiated by localized introduction
of an additional ectopic GFP
transgene. The RNA silencing is
initially manifested in the tissues
containing the ectopic DNA but
eventually becomes systemic
showing that a silencing signal
moves between cells and in the
vascular system of the plant
(Figure 3). The production and
movement of this signal persists
throughout the lifetime of the plant
even if the tissues containing the
ectopic initiator are removed.
Thus, the cells containing the
ectopic DNA are not the only
source of silencing signal; as the
signal moves through the plant
there must be a system that
amplifies the effects of the
initiator of silencing.
Animals may also have a system
for amplification and spread of
silencing. This is shown most
graphically by C.elegans. If these
animals are injected with dsRNA
or if they are allowed to feed on
bacteria that produce dsRNA
there is systemic silencing of a
corresponding endogenous RNA.
Presumably the signal molecule is
produced in the C. elegans cells
that receive dsRNA. This signal
then moves and causes RNA
silencing in other cells that become
sources of secondary signal.
We know that an RNA-
dependent RNA polymerase is
required to amplify RNA molecules
involved in RNA silencing. However,
we do not know the nature of the
signal although the siRNAs are a
good candidate. Nor do we
understand why there is the
potential for extracellular signaling
and amplification of silencing. One
possible explanation concerns
antiviral defense. If silencing of
viruses occurs in the cells that are
yet to be infected then the antiviral
defense role of silencing will be
more effective than a system that
operates only after the virus has
started to replicate. Other roles of
systemic silencing in develop-
mental control are also possible.
Natural roles of RNA silencing
RNA silencing is more than an
artefact of transgenic plants or
C. elegans injected with double-
stranded RNA. It also has natural
roles in antiviral defense, genome
protection and developmental
regulation of gene expression. An
antiviral defense role, at least for
RNA viruses in plants, is thought to
involve dsRNA intermediates in
viral RNA replication. This dsRNA
is processed by DICER so that,
once the infection is established,
RISC is targeted against the viral
mRNAs and virus replication is
slowed down. Not surprisingly
plant viruses produce proteins that
counteract RNA silencing and this
might explain why some strains are
highly virulent. At present it is not
known whether viruses in animals
or affected by RNA silencing.
An example of RNA silencing in
development involves short
temporal (st)RNAs. stRNAs were
discovered in C. elegans; they are
about 21 nucleotides long and are
produced by DICER-mediated
Figure 2. The schematic of the basic




Sequence specific nuclease (RISC)
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processing of ds precursor RNAs.
stRNAs are complementary to and
repress the expression of longer
RNAs. However, unlike other
examples of RNA silencing, the
block is at the level of translation
rather than enhanced degradation.
A role for the RNA silencing in
genome protection is shown by
C. elegans mutants that are
defective in RNA silencing and in
which there is a high frequency of
spontaneous mutation due to
enhanced mobility of transposable
DNA. In principle this genome
protection could be targeted
through the DICER/RISC process
at mRNAs of enzymes required for
DNA transposition. However, from
work in plants we know that some
examples of RNA silencing lead to
methylation of the target DNA as
well as degradation of the target
RNA. These findings indicate that
suppression of transposable
elements in C. elegans and
Drosophila could be mediated by
the effect of RNA silencing on DNA
or chromatin. If this is the case,
the RNA silencing mechanism will
be more complex than shown in
Figure 2.
Functional genomics and RNA
silencing
RNA silencing is well suited to the
systematic analysis of gene
function. The principle is simple: a
fragment of a gene is introduced
into a cell as dsRNA or as DNA
that will give rise to dsRNA. The
dsRNA activates the DICER/RISC
process so that the properties of
the affected cell reflect a loss of
function in the corresponding
gene. In order to target the
genome of C. elegans a collection
of E. coli strains has been
generated to produce dsRNA
corresponding to each gene. 
The function of each gene is
inferred from the behaviour or
properties of the C. elegans after
feeding on the E. coli. A parallel
programme is being carried out in
plants infected with viruses
carrying inserts corresponding to
each of the genes in the plant
genome. The function of the gene
can be inferred from the
symptoms that develop in the
infected plant.
A particularly useful property of
RNA silencing is that it does not
require complete sequence
identity in the dsRNA and the
target RNA. There is good
silencing even if there is 5% or
10% mismatch in the initiator of
silencing and the target RNA.
Thus it is possible to investigate
the function of multigene families
in which different members have
overlapping and redundant roles.
These families are otherwise
difficult to investigate by genetic
means. Over the next year or two I
expect that RNA silencing will be
used for systematic analysis of
the genes in several organisms.
Applications of RNA Silencing
One of the first commercial
products of RNA silencing was a
tomato in which the target was a
gene required for softening of
ripening fruit. Reduced expression
of this gene in the silenced plants
meant that the tomatoes were firm
after ripening and were not
damaged by handling. They could
be left to ripen on the vine and so
tasted better than conventional
tomatoes that are harvested green.
There are many other applications
in agriculture where crop
production or product quality can
be enhanced by specific
suppression of gene expression
by RNA silencing. Previously one
of the barriers to these applications
was the hit and miss nature of RNA
silencing in transgenic plants.
Normally only a few percent of
lines with any one construct would
manifest the silencing phenotype.
Now that we understand more
about the silencing mechanism, it
is possible to produce more
consistent silencing and,
conditional on public acceptance
of transgenic plants, we can
expect other products based on
this technology.
There may also be applications
of RNA silencing in transgenic
animals. For example, an animal
could be engineered to produce a
short dsRNA corresponding to the
conserved region of a virus. The
dsRNA would not activate the PKR
system because it was short.
However, through RNA silencing, it
would condition the animal to be
constitutively resistant to the virus.
There are also potential
applications in gene therapy. If
siRNAs targeted against a gene
required for cell proliferation could
be introduced into cancer cells it is
possible that the growth of a tumor
could be suppressed. Is it not
amazing how a process that was
first described in plants only a few
years ago is now being considered
as part of anti-cancer therapy?
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Figure 3 Systemic silencing in plants.
The image shows a leaf of a GFP
transgenic plant under UV light. The
background green fluorescence is due to
expression of the GFP transgene which is
so strong that the normal red fluorescence
of chlorophyll is masked. The red regions
around the veins are due to RNA silencing
that is mediated by a signal of silencing
that has been transmitted through the
vascular system from the lower parts of
the plant.
